Literature DB >> 3548879

Anterior thalamic mediation of generalized pentylenetetrazol seizures.

M A Mirski, J A Ferrendelli.   

Abstract

The effects of microinjection of various neuroactive compounds into the anterior thalamic nucleus (AN) and other selected subcortical regions of guinea pig brain on the expression of pentylenetetrazol (PTZ)-induced behavioral and electrical seizure activity were examined. Excitatory agents, kainic acid (KA), bicuculline (BIC) or PTZ, injected into the AN or other thalamic nuclei, striatum, but not the mammillary bodies (MB), facilitated the EEG convulsant action of systemically administered PTZ. Injection of muscimol into the AN protected against the expression of PTZ-induced repetitive high-voltage EEG seizure discharges and inhibited the facilitatory effects of subcortically applied KA or BIC. Injection of muscimol into the AN was also able to terminate established ongoing seizure discharges. Unilateral application of muscimol to the AN did not prevent the repetitive hypersynchronous EEG discharges following systemic PTZ but did result in the delay in the onset of cortical hypersynchrony in the ipsilateral hemisphere. Muscimol injections into other thalamic nuclei, MB, cortex, striatum or directly into the CSF space had no anticonvulsant effect, however. Microinjection of gamma-vinyl-gamma-aminobutyric acid, a selective GABA transaminase inhibitor, resulted in protection from the behavioral convulsant action and lethal effects of PTZ when administered into the thalamus, especially the AN, but not when injected into the striatum or CSF. These data demonstrate that the AN is an important subcortical nucleus for the mediation of both cortical EEG synchrony and behavioral seizure expression induced by PTZ. In light of previous results establishing a role for the brainstem and diencephalon in PTZ seizure expression, the AN may serve, in part, as a gating mechanism for the propagation of paroxysmal activity between subcortical areas and the cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3548879     DOI: 10.1016/0006-8993(86)91511-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

1.  Deep brain stimulation for intractable epilepsy: which target and for which seizures?

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2004 Nov-Dec       Impact factor: 7.500

2.  Normal acute behavioral responses to moderate/high dose ethanol in GABAA receptor alpha 4 subunit knockout mice.

Authors:  Dev Chandra; David F Werner; Jing Liang; Asha Suryanarayanan; Neil L Harrison; Igor Spigelman; Richard W Olsen; Gregg E Homanics
Journal:  Alcohol Clin Exp Res       Date:  2007-12-12       Impact factor: 3.455

Review 3.  Neurostimulation for drug-resistant epilepsy.

Authors:  Christopher M DeGiorgio; Scott E Krahl
Journal:  Continuum (Minneap Minn)       Date:  2013-06

4.  Chemogenetic silencing of the midline and intralaminar thalamus blocks amygdala-kindled seizures.

Authors:  Evan Wicker; Patrick A Forcelli
Journal:  Exp Neurol       Date:  2016-07-09       Impact factor: 5.330

Review 5.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

6.  Analysis of gene expression changes in the rat hippocampus after deep brain stimulation of the anterior thalamic nucleus.

Authors:  Tharakeswari Selvakumar; Kambiz N Alavian; Travis Tierney
Journal:  J Vis Exp       Date:  2015-03-08       Impact factor: 1.355

7.  Epilepsy treatment stimulus package? Deep brain stimulation in treatment-resistant focal epilepsy.

Authors:  Chad Carlson
Journal:  Epilepsy Curr       Date:  2010-11       Impact factor: 7.500

8.  Enhancing GAT-3 in thalamic astrocytes promotes resilience to brain injury in rodents.

Authors:  Frances S Cho; Ilia D Vainchtein; Yuliya Voskobiynyk; Allison R Morningstar; Francisco Aparicio; Bryan Higashikubo; Agnieszka Ciesielska; Diede W M Broekaart; Jasper J Anink; Erwin A van Vliet; Xinzhu Yu; Baljit S Khakh; Eleonora Aronica; Anna V Molofsky; Jeanne T Paz
Journal:  Sci Transl Med       Date:  2022-07-06       Impact factor: 19.319

9.  Effect of vigabatrin (gamma-vinyl GABA) on amino acid levels in CSF of epileptic patients.

Authors:  A Pitkänen; R Matilainen; T Ruutiainen; M Lehtinen; P Riekkinen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-11       Impact factor: 10.154

Review 10.  [Electric brain stimulation for epilepsy therapy].

Authors:  C Kellinghaus; T Loddenkemper; G Möddel; F Tergau; J Lüders; P Lüdemann; D R Nair; H O Lüders
Journal:  Nervenarzt       Date:  2003-08       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.